BIOMAT Database Logo BIOMAT Database Logo

[Ethambutol excretion in tuberculous patients with moderately impaired renal function]. 1973

F Zeller, and L Róka

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

F Zeller, and L Róka
Ethambutol kinetics in patients with impaired renal function.
July 1986, The American review of respiratory disease,
F Zeller, and L Róka
Plasma concentration and urinary excretion of arginine vasopressin in children with moderately impaired renal function.
January 1988, Child nephrology and urology,
F Zeller, and L Róka
D-xylose absorption and disposition in patients with moderately impaired renal function.
March 1987, Clinical pharmacology and therapeutics,
F Zeller, and L Róka
Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
October 1985, British journal of clinical pharmacology,
F Zeller, and L Róka
Cephaloridine excretion in patients with normal and impaired renal function.
August 1967, Postgraduate medical journal,
F Zeller, and L Róka
[Urinary glycosaminoglycan excretion with impaired renal function].
August 1982, Nihon Jinzo Gakkai shi,
F Zeller, and L Róka
Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function.
June 1998, European journal of clinical investigation,
F Zeller, and L Róka
Ethambutol absorption, excretion and dosage in patients with renal tuberculosis.
March 1970, Chemotherapy,
F Zeller, and L Róka
The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function.
May 1996, Anesthesia and analgesia,
F Zeller, and L Róka
Renal haemodynamic effects of bunazosin retard and prazosin in mild to moderately hypertensive patients with normal or moderately impaired renal function.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!